National Cancer Institute
National Cancer Institute U.S. National Institutes of Health

Clinical Trials Reporting Program (CTRP)

"We want to streamline the process and minimize the reporting burden on our investigators."
John Speakman
NCI Center for Biomedical Informatics and Information Technology

The Problem
Standard reporting of cancer clinical trial data would be of benefit in terms of cost-effectiveness and comparability of results across trials and sites. Such standards would provide reporting applications that are interoperable among the various research stakeholders, and would reduce data requirements and the need for investigative sites to manage a wide array of different forms and data entry processes. (Coordination Initiative 1).

The Solution
Fulfilling a key recommendation from the NCI Clinical Trials Working Group, all trials conducted at NCI-designated Cancer Centers and all NCI-funded trials conducted elsewhere will be registered in a central database as part of the new Clinical Trials Reporting Program (CTRP).

The purpose of the program is to establish a comprehensive database containing regularly updated information on all NCI-funded interventional clinical trials. Grantees will enter specific information about each clinical trial into the database. NCI will use this information to coordinate research efforts to optimize our nation's investment in cancer research.

The Results
A phased launch beginning in 2009 is underway. For more information or to see the reporting schedule, please visit NCI's Clinical Trials Reporting Program Web site. If you have questions about the NCI Clinical Trials Reporting Program, please email